LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
+5.39%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$749M
AUM Growth
+$749M
Cap. Flow
+$23.7M
Cap. Flow %
3.17%
Top 10 Hldgs %
54.66%
Holding
60
New
18
Increased
9
Reduced
11
Closed
12

Top Buys

1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$47.8M
2
BIIB icon
Biogen
BIIB
$25.1M
3
UTHR icon
United Therapeutics
UTHR
$24.4M
4
ARVN icon
Arvinas
ARVN
$24.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
$18.9M

Top Sells

1
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
$78.2M
2
NUVL icon
Nuvalent
NUVL
$35.5M
3
TEVA icon
Teva Pharmaceuticals
TEVA
$26.1M
4
UNCY icon
Unicycive Therapeutics
UNCY
$22M
5
XENE icon
Xenon Pharmaceuticals
XENE
$21.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MLTX icon
26
MoonLake Immunotherapeutics
MLTX
$3.54B
$9.44M 1.04%
200,000
-150,000
-43% -$7.08M
CDTX icon
27
Cidara Therapeutics
CDTX
$1.66B
$9.25M 1.02%
+190,000
New +$9.25M
CBIO
28
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$8.94M 0.99%
553,686
-4,846,314
-90% -$78.2M
LEGN icon
29
Legend Biotech
LEGN
$6.41B
$8.87M 0.98%
+250,000
New +$8.87M
RYTM icon
30
Rhythm Pharmaceuticals
RYTM
$6.85B
$8.21M 0.91%
+130,000
New +$8.21M
MAZE
31
Maze Therapeutics, Inc. Common Stock
MAZE
$635M
$7.51M 0.83%
611,914
-325,000
-35% -$3.99M
ELVN icon
32
Enliven Therapeutics
ELVN
$1.2B
$7.02M 0.78%
350,000
+110,000
+46% +$2.21M
JBIO
33
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$6.24M 0.69%
625,000
-775,000
-55% -$7.74M
ANNX icon
34
Annexon
ANNX
$226M
$5.78M 0.64%
2,410,000
-1,590,000
-40% -$3.82M
MTSR
35
Metsera, Inc. Common Stock
MTSR
$3.71B
$5.69M 0.63%
+200,000
New +$5.69M
TRVI icon
36
Trevi Therapeutics
TRVI
$883M
$4.65M 0.51%
850,000
+425,285
+100% +$2.33M
IMVT icon
37
Immunovant
IMVT
$2.56B
$4.4M 0.49%
275,000
– –
VSTM icon
38
Verastem
VSTM
$569M
$4.15M 0.46%
+1,000,000
New +$4.15M
ATXS icon
39
Astria Therapeutics
ATXS
$349M
$3.75M 0.42%
700,000
+200,000
+40% +$1.07M
BCAX
40
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
$3.72M 0.41%
+400,000
New +$3.72M
ACRS icon
41
Aclaris Therapeutics
ACRS
$209M
$2.63M 0.29%
1,850,000
-372,222
-17% -$529K
RAPP
42
Rapport Therapeutics
RAPP
$643M
$2.38M 0.26%
208,910
– –
UNCY icon
43
Unicycive Therapeutics
UNCY
$74M
$2.26M 0.25%
473,562
-4,605,365
-91% -$22M
SEPN
44
Septerna, Inc. Common Stock
SEPN
$539M
$1.15M 0.13%
109,202
-25,000
-19% -$264K
NUVB.WS icon
45
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$18K ﹤0.01%
66,666
– –
ALLK
46
DELISTED
Allakos
ALLK
– –
-2,900,000
Closed -$660K
APLS icon
47
Apellis Pharmaceuticals
APLS
$3.48B
– –
0
– –
BNTX icon
48
BioNTech
BNTX
$24B
– –
-200,000
Closed -$18.2M
CMPS
49
Compass Pathways
CMPS
$424M
– –
-2,000,000
Closed -$5.72M
CRNX icon
50
Crinetics Pharmaceuticals
CRNX
$2.92B
– –
-350,000
Closed -$11.7M
1
2
3